SONG PAUL Y. (Chief Executive Officer) purchased 12184.2% of their position (20.85M shares) of NKGEN BIOTECH, INC. on the open market
Open‑market purchase worth $2.65M — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/7/2025ACC: 0001213900-25-040627
DirectorOfficer· Chief Executive Officer
Since Sep 2023
+62.55M
Net shares
Net buyer
$2.65M
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
62.55M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+20.85M
Price / share
$0.13
Trade value
$2.65M
% of position
12184.2%
5/5/2025
171.12K→21.02M
Total
Net shares
+20.85M
Net value
$2.65M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/5/2025 | P · Purchase | +20.85M | $0.13 | $2.65M | 12184.2% | 171.12K | 21.02M |
| Total | +20.85M | $2.65M | ||||||
Derivative Transactions1
Warrant
Direct
Converts to
Common Stock
41.70M shares
Shares
+41.70M
Strike price
0.1271
Held after
41.70M
Exercisable
—
5/5/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrant Direct | Common Stock41.70M shares | 5/5/2025 | P · Purchase | +41.70M | 0.1271 | — | 41.70M |